Literature DB >> 11073561

Long-term peritoneal membrane changes.

G A Coles1, N Topley.   

Abstract

There is increasing evidence that long-term peritoneal dialysis (PD) is associated with structural changes in the peritoneal membrane. These consist of thickening of the sub-mesothelial space owing to collagen deposition and alterations in small blood vessel morphology. These alterations become more pronounced with duration of PD therapy. These changes are associated with a tendency to increasing small solute transport rate with reduced ultrafiltration. The relationship between these structural and functional changes remains unknown, but the evidence suggests that both peritonitis and exposure to dialysate contribute. The most likely components of the fluid responsible for this effect are glucose and/or its degradation products generated during heat sterilisation. Serial monitoring of peritoneal function is well established, but repeat biopsies are not practical. Effluent markers are not yet of proven value but do alter in response to a change in dialysate composition. Hopefully, a combination of reduced inflammation and more biocompatible fluids will reduce long-term changes in peritoneal membrane structure and function with a consequent improvement in patient and technique survival. Copyright 2000 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 11073561     DOI: 10.1053/jarr.2000.16268

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  8 in total

1.  A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation.

Authors:  Caatje Y le Poole; Angelique G A Welten; Piet M ter Wee; Nanne J Paauw; Amina N Djorai; Rob M Valentijn; Robert H J Beelen; Jacob van den Born; Frans J van Ittersum
Journal:  Perit Dial Int       Date:  2011-11-01       Impact factor: 1.756

2.  Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility.

Authors:  A T N van Diepen; A M Coester; C J Janmaat; F W Dekker; D G Struijk; R T Krediet
Journal:  Kidney Int Rep       Date:  2020-10-10

3.  Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan--10 years' experience in a single center.

Authors:  Yao-Peng Hsieh; Chia-Chu Chang; Yao-Ko Wen; Ping-Fang Chiu; Yu Yang
Journal:  Perit Dial Int       Date:  2013-10-01       Impact factor: 1.756

4.  Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid.

Authors:  S Tang; J C K Leung; L Y Y Chan; A W L Tsang; C X R Chen; W Zhou; K N Lai; S H Sacks
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

5.  Thalidomide prevents the progression of peritoneal fibrosis in mice.

Authors:  Hideyuki Arai; Akira Furusu; Tomoya Nishino; Yoko Obata; Yuka Nakazawa; Masayuki Nakazawa; Misaki Hirose; Katsushige Abe; Takehiko Koji; Shigeru Kohno
Journal:  Acta Histochem Cytochem       Date:  2011-04-21       Impact factor: 1.938

6.  Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice.

Authors:  Masayuki Nakazawa; Yoko Obata; Tomoya Nishino; Shinichi Abe; Yuka Nakazawa; Katsushige Abe; Akira Furusu; Masanobu Miyazaki; Takehiko Koji; Shigeru Kohno
Journal:  Acta Histochem Cytochem       Date:  2013-04-12       Impact factor: 1.938

Review 7.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

8.  Vitamin D can ameliorate chlorhexidine gluconate-induced peritoneal fibrosis and functional deterioration through the inhibition of epithelial-to-mesenchymal transition of mesothelial cells.

Authors:  Yi-Che Lee; Shih-Yuan Hung; Hung-Hsiang Liou; Tsun-Mei Lin; Chu-Hung Tsai; Sheng-Hsiang Lin; Yau-Sheng Tsai; Min-Yu Chang; Hsi-Hao Wang; Li-Chun Ho; Yi-Ting Chen; Ching-Fang Wu; Ho-Ching Chen; Hsin-Pao Chen; Kuang-Wen Liu; Chih-I Chen; Kuan Min She; Hao-Kuang Wang; Chi-Wei Lin; Yuan-Yow Chiou
Journal:  Biomed Res Int       Date:  2015-10-01       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.